Concepedia

Patrik Johansson

PJ

19

Publications

1K

Citations

18

H-Index

2009

Active since

Affiliations

AstraZeneca (Sweden)(Current)

Max Planck Institute of Biochemistry

Max Planck Society

Uppsala University

AstraZeneca (United States)

Patrik Johansson is an author at AstraZeneca (Sweden) specializing in medicine, biochemistry, and drug discovery.

ORCID

Top concepts

Publications per year

2009–2023

19

Publications

19

Structural insight into allosteric modulation of protease-activated receptor 2

R.K. Cheng, Cédric Fiez-Vandal, Oliver Schlenker et al. · Nature · 2017 · 246 citations

, , +6

MraY–antibiotic complex reveals details of tunicamycin mode of action

Jonna Hakulinen, Jenny Hering, Gisela Brändén et al. · Nature Chemical Biology · 2017 · 117 citations · Full text

, , +9

Crystal structure of microsomal prostaglandin E<sub>2</sub>synthase provides insight into diversity in the MAPEG superfamily

Tove Sjögren, Johan Nord, Margareta Ek et al. · Proceedings of the National Academy of Sciences · 2013 · 98 citations · Full text

Genetic variations in A20 DUB domain provide a genetic link to citrullination and neutrophil extracellular traps in systemic lupus erythematosus

Lina Odqvist, Zala Jevnikar, Rebecca Riise et al. · Annals of the Rheumatic Diseases · 2019 · 74 citations · Full text

New Aminoimidazoles as β-Secretase (BACE-1) Inhibitors Showing Amyloid-β (Aβ) Lowering in Brain

Ylva Gravenfors, Jenny Viklund, Jan Blid et al. · Journal of Medicinal Chemistry · 2012 · 65 citations · Full text

, , +23

Rows per page

1–5 of 19